M.KH. VALEEV, N.R. KHASANOV

Kazan Federal University, Kazan

 Contact details:

Valeev M.K. — cardiologist

Address: 1a Chekhov St., Kazan, Russian Federation, 420012, tel.: +7-917-882-82-41, e-mail: vmh89@mail.ru

Atrium fibrillation is one of the most frequent rhythm disruptions in patients with COVID infection. Restoration and maintenance of the sinus rhythm helps to improve hemodynamics and reduce the risks of cardiovascular complications. The article presents the data of restoring the sinus rhythm with a pharmacological cardioversion in patients after COVID infection with varied intensity of lung lesions and the duration of the sinus rhythm maintenance during 12 months of observation. The research results showed the connection between atrium fibrillation restoration with the intensity of lung lesions against the background of the past COVID infection.

Key words: atrium fibrillation, pharmacological cardioversion, maintenance of the sinus rhythm, COVID-19 pneumonia.

REFERENCES

1. Manolis A.S., Pantos C., Mourouzis I., Pastromas S., Triantafyllou K., Anninos H., Rouska E. Cardiovascular complications of the Coronavirus (COVID-19) infection. Rhythmos, 2020, vol. 15 (2), rr. 23–28.
2. Driggin E., Madhavan M.V., Bikdeli B., Chuich T., Laracy J., Bondi-Zoccai G., Brown T.S., Nigoghossian C., Zidar D.A., Haythe J., Brodie D., Beckman J.A., Kirtane A.J., Stone G.W., Krumholz H.M., Parikh S.A. Cardiovascular considerations for patients, health care workers, and health systems during the coronavirus disease 2019 (COVID-19) pandemic. J Am Coll Cardiol, 2020, vol. 75, rr. 2352–2371.
3. Bosch N.A., Cimini J., Walkey A.J. Atrial fibrillation in the ICU. Chest, 2018, vol. 154, pp. 1424–1434.
4. Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., Wang B., Xiang H., Cheng Z., Xiong Y., Zhao Y., Li Y., Wang X., Peng Z. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus‐infected pneumonia in Wuhan, China. JAMA, 2020, vol. 323, pp. 1061–1069.
5. Kow C.S., Thiruchelvam K., Hasan S.S. Pharmacotherapeutic considerations for the management of cardiovascular diseases among hospitalized COVID-19 patients. Expert Review of Cardiovascular Therapy [Online journal], 2020. 1797492.
6. Fibrillyatsiya i trepetanie predserdiy. Klinicheskie rekomendatsii. Rossiyskoe kardiologicheskoe obshchestvo [Fibrillation and atrial flutter. Clinical guidelines. Russian Society of Cardiology], 2020, 184 p., available at: https://scardio.ru/content/Guidelines/2020/Clinic_rekom_FP_TP.pdf
7. Denegri A., Morelli M., Pezzuto G., Malavasi V.L., Boriani G. Atrial fibrillation increases mortality in COVID-19. Cardiology Journal, 2021, vol. 28 (6), pp. 1–3. DOI: 10.5603/CJ.a2021.0102
8. Rattanawong P., Shen W., Masry H.E., Sorajja D., Srivathsan K., Valverde A., Scott L.R., Guidance on Short-Term Management of Atrial Fibrillation in Coronavirus Disease 2019. J Am Heart Assoc, 2020, vol. 9 (14), pp: 017529. DOI: 10.1161/JAHA.120.017529